《Table 2 Combination therapy of stem cells with neurotrophic factors in Parkinson’s disease》

《Table 2 Combination therapy of stem cells with neurotrophic factors in Parkinson’s disease》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

In an in vitro HD model of R6/2 mice-derived neuronal cells，exosomes derived from adipose stem cells（ASC-exo）significantly decreased the mHtt aggregates，reduced abnormal apoptotic protein level，mitochondrial dysfunction and cell apoptosis，suggesting a therapeutic potentiality of ASC-exo for HD[82].

图表编号XD00173733200    严禁用于非法目的
绘制时间2020.05.26
作者Jie Wang、Wei-Wei Hu、Zhi Jiang、Mei-Jiang Feng
绘制单位Department of Geriatrics, the Second Affiliated Hospital of Nanjing Medical University、Department of Neurology, the Affiliated Jiangning Hospital of Nanjing Medical University、Department of Geriatrics, Jinling Hospital, Medical School of Nanjing Universit
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 4 Combination therapy of stem cells with neurotrophic factors in amyotrophic lateral sclerosis》2020.05.26
  2. 《Table 4 Combination therapy of stem cells with neurotrophic factors in amyotrophic lateral sclerosis》2020.05.26
  3. 《Table 3 Combination therapy of stem cells with neurotrophic factors in Huntington's disease》2020.05.26
  4. 《Table 2A comparison of the technologies used to build eight SCFLs with a BIT combination.》2019.02.01
  5. 《Table 1 Indication of autologous hematopoietic stem cell transplantation in autoimmune diseases》2019.04.26
  6. 《Table 1.Effects on Stem Cells and Associated Mechanisms of Compounds Derived from Chinese Herbs》2019.01.01
  7. 《Table 1 The coefficient of drug interaction (CDI) after equol in combination with cisplatin treatment》2019.02.28
  8. 《Tab.1 Information of the included literatures in the Meta analysis of stem cell therapies for patients with ischemic str》2019.03.15
  9. 《Table 1 Studies of pharmacological therapies with immunomodulatory properties in animal models of Alzheimer’s disease (A》2019.07.01
  10. 《Table 1 Studies of pharmacological therapies with immunomodulatory properties in animal models of Alzheimer’s disease (A》2019.07.01
  11. 《Table 1 Studies of pharmacological therapies with immunomodulatory properties in animal models of Alzheimer’s disease (A》2019.07.01
  12. 《Table 2 Studies of cell-based therapies with immunomodulatory properties in animal models of Alzheimer’s disease (AD)》2019.07.01
  13. 《Table 2 Studies of cell-based therapies with immunomodulatory properties in animal models of Alzheimer’s disease (AD)》2019.07.01
  14. 《Table 1 Transplantation of exogenous neural stem cells in the treatment of cerebral ischemia》2019.07.01
  15. 《Table 1 Some key scientific questions of primate pluripotent stem cells.The labels“+”indicate that the question has been》2019.01.05
  16. 《Table 2 Morphological comparison of cells from samples with Cladophora fracta》2019.01.01
  17. 《表2 氯吡格雷与5种质子泵抑制药 (PPI) 的合用例数 (2012~2016年) Table 2 Combination use of clopidogrel with five proton pump in-hibitor (PPI)》2018.06.17
  18. 《Table 3 Examples of three-dimensional research systems utilized for cancer and stem cell cancer studies》2019.12.26
  19. 《Table 3 Examples of three-dimensional research systems utilized for cancer and stem cell cancer studies》2019.12.26
  20. 《Table 3 Examples of three-dimensional research systems utilized for cancer and stem cell cancer studies》2019.12.26

随机翻阅

《表3 孕期膳食变化对抑郁影响的单因素分析》 《表8 贴膜法试验结果（马丁代尔测试前）》 《表8 不同学校的生师比例对比》 《表4 不同流程数下的优化方案》 《表8 中欧重力式码头结构抗倾设计方法计算结果比较》 《表1 液压张紧系统的性能指标》 《表4 空间杜宾模型SDM估计结果》 《表1 模型类型：横系梁设置对双柱墩抗震性能的影响分析》 《表1 城市竞争力评价指标体系一览表》 《表1 两组静脉留置时间及非计划撤管发生率比较[n (%) ]》